Hubei Guangji Pharmaceutical Co., Ltd. (SZSE: 000952)
Health Care · Pharmaceuticals · CN
CN¥6.38
+1.11% today · -6.5% 1Y
Hubei Guangji Pharmaceutical Co., Ltd. (SZSE: 000952) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $329.09M and employs 1,164 people.
Over the last twelve months the share price has lost 6.5%, trading between 5.00 and 10.42.
Tweenvest scores Hubei Guangji Pharmaceutical Co., Ltd. across four factors: quality 56/100, value 52/100, growth 0/100. Its strongest factor is quality.
000952 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $329.09M
- Revenue (TTM)
- $92.58M
- P/E
- —
- EPS
- -1.15
- Dividend yield
- —
- Beta (5Y)
- 0.24
- 52-week high
- CN¥10.42
- 52-week low
- CN¥5.00
- Avg volume (3M)
- —
- Shares outstanding
- 346.75M
- Employees
- 1,164
- Next earnings
- —
About Hubei Guangji Pharmaceutical Co., Ltd.
Hubei Guangji Pharmaceutical Co., Ltd. engages in the production and operation of pharmaceutical raw materials, pharmaceutical preparations, and feed additives. It specializes in production of vitamin B2, B6 and pharmaceutical products. Vitamin B2, is also known as riboflavin. it is used in medicine APIs (Active Pharmaceutical Ingredient), feed additives, and food additives. Its products are divided into raw material series products and preparation series products. The series of raw materials are pharmaceutical grade, food grade, 98% feed grade, 80% feed grade nuclear yellow and riboflavin sodium phosphate. The preparation series products are oral solid preparations and large infusions. The company was founded on May 28, 1993 and is headquartered in Wuxue, China.
- ISIN
- CNE0000010R5
- Founded
- 1969
- Listed since
- Nov 12, 1999
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.